Acrospire Investment Management LLC - INTELLIPHARMACEUTICS INTL IN ownership

INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 24 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q1 2017. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of INTELLIPHARMACEUTICS INTL IN
ValueSharesWeighting
Q1 2017$27,000
+92.9%
10,777
+115.5%
0.02%
+266.7%
Q4 2016$14,000
+366.7%
5,000
+233.3%
0.01%
+200.0%
Q3 2016$3,000
-50.0%
1,500
-59.5%
0.00%
-50.0%
Q2 2016$6,000
+50.0%
3,700
+76.2%
0.00%
+33.3%
Q1 2016$4,0002,1000.00%
Other shareholders
INTELLIPHARMACEUTICS INTL IN shareholders Q1 2017
NameSharesValueWeighting ↓
Atria Investments, Inc 75,895$159,0000.02%
FIRST FOUNDATION ADVISORS 100,900$212,0000.02%
Argent Trust Co 15,121$32,0000.01%
Acrospire Investment Management LLC 1,500$3,0000.00%
Virtu KCG Holdings LLC 33,485$70,0000.00%
SIMPLEX TRADING, LLC 9,846$20,0000.00%
Advisor Group, Inc. 11,791$25,0000.00%
Hudson Bay Capital Management LP 10,000$21,0000.00%
BANK OF AMERICA CORP /DE/ 6$00.00%
WELLS FARGO & COMPANY/MN 1,038$2,0000.00%
View complete list of INTELLIPHARMACEUTICS INTL IN shareholders